Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chattem ephedra

This article was originally published in The Tan Sheet

Executive Summary

Roughly $2 mil. to $2.5 mil. in ephedra-containing Dexatrim remained on retail shelves as of March, although all such products "should be off shelves by May," Chattem tells investors April 3 at Banc of America Securities Consumer Conference. Chattanooga, Tenn.-based firm took $750,000 hit in Q1 to replace product with new formulation, execs add. Despite charge, first quarter revenue reached $58.4 mil., a 20.7% increase over year-ago period, attributable in part to growing Selsun Blue sales (1"The Tan Sheet" March 24, 2003, In Brief)...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS095309

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel